Association of Systemic Inflammatory Response Index (SIRI) With Severity of Coronary Artery Disease in Patients With Coronary Heart Disease: A CSCD-TCM Plus Study
Restricted accessResearch articleFirst published online 2025
Association of Systemic Inflammatory Response Index (SIRI) With Severity of Coronary Artery Disease in Patients With Coronary Heart Disease: A CSCD-TCM Plus Study
The systemic inflammation response index (SIRI) is a novel inflammatory biomarker that reflects the chronic inflammatory status. This study aimed to evaluate its clinical utility in determining coronary heart disease (CHD) severity. Participants in this study, sourced from the Cohort Study on the Treatment of Cardiovascular Diseases with Traditional Chinese Medicine (CSCD-TCMplus), were divided into tertiles (T) based on their SIRI values. The number of diseased vessels (single- and multi-vessel CHD) was used as a measure of disease severity, assessed by coronary angiography. Logistic regression analysis was used to investigate the relationship between SIRI and the severity of CHD. Among the 7706 participants, 6215 (80.6%) had multi-vessel disease. Logistic regression analysis revealed a significant association between SIRI and CHD severity (odds ratio [OR]: 1.09; 95% confidence interval [CI]: 1.03-1.15). Compared with males, females had a higher risk of CHD severity at the SIRI T3 tertile (OR: 1.64; 95% CI: 1.28-2.10). Also, patients >55 years of age had a greater risk than those ≤55 years old (OR: 1.93; 95% CI: 1.67-2.01). The association between SIRI and CHD severity persisted even after adjusting for confounding factors.
XingDZhuMLiuCWangH.Outcome measures in clinical trials of traditional Chinese medicine for stable angina pectoris. Acupunct Herb Med. 2021;1(2):99-106.
3.
RothGAMensahGAJohnsonCO, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982-3021.
4.
WangZMaLLiuMFanJHuS; Writing Committee of the Report on Cardiovascular Health and Diseases in China. Summary of the 2022 report on cardiovascular health and diseases in China. Chin Med J. 2023;136(24):2899-2908.
5.
National Center for Cardiovascular Diseases the Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on cardiovascular health and diseases in China 2023: an updated summary. Biomed Environ Sci. 2024;37(9):949-992.
6.
ViraniSSAlonsoAAparicioHJ, et al. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 2021;143(8):e254-e743.
7.
LinPJiHHLiYJGuoSD.Macrophage plasticity and atherosclerosis therapy. Front Mol Biosci. 2021;8:679797.
8.
PencinaMJNavarAMWojdylaD, et al. Quantifying importance of major risk factors for coronary heart disease. Circulation. 2019;139(13):1603-1611.
9.
DziedzicEAGąsiorJSTuzimekA, et al. Investigation of the associations of novel inflammatory biomarkers-systemic inflammatory index (SII) and systemic inflammatory response index (SIRI)-with the severity of coronary artery disease and acute coronary syndrome occurrence. Int J Mol Sci. 2022;23(17):9553.
10.
AkhtarMAshrafDANadeemMS, et al. Trends in atherosclerotic heart disease-related mortality among U.S. adults aged 35 and older: a 22-year analysis. Int J Cardiol Cardiovasc Risk Prev. 2025;24:200374.
11.
LiuYLiZWangX, et al. Effects of adjuvant Chinese patent medicine therapy on major adverse cardiovascular events in patients with coronary heart disease angina pectoris: a population-based retrospective cohort study. Acupunct Herb Med. 2022;2(2):109-117.
12.
KaplanRCFrishmanWH.Systemic inflammation as a cardiovascular disease risk factor and as a potential target for drug therapy. Heart Dis. 2001;3(5):326-332.
13.
JinZWuQChenS, et al. The associations of two novel inflammation indexes, SII and SIRI with the risks for cardiovascular diseases and all-cause mortality: a ten-year follow-up study in 85,154 individuals. J Inflamm Res. 2021;14:131-140.
14.
WangXNiQWangJWuSChenPXingD.Systemic inflammation response index is a promising prognostic marker in elderly patients with heart failure: a retrospective cohort study. Front Cardiovasc Med. 2022;9:871031.
15.
ZhaoSDongSQinYWangYZhangBLiuA.Inflammation index SIRI is associated with increased all-cause and cardiovascular mortality among patients with hypertension. Front Cardiovasc Med. 2023;9:1066219.
16.
XiaYXiaCWuLLiZLiHZhangJ.Systemic immune inflammation index (SII), system inflammation response index (SIRI) and risk of all-cause mortality and cardiovascular mortality: a 20-year follow-up cohort study of 42,875 US adults. J Clin Med. 2023;12(3):1128.
17.
NiccoliGMontoneRASabatoVCreaF.Role of allergic inflammatory cells in coronary artery disease. Circulation. 2018;138(16):1736-1748.
18.
HarringtonRA.Targeting inflammation in coronary artery disease. N Engl J Med. 2017;377(12):1197-1198.
19.
AbeteILuYLassaleCVerschurenMVan Der SchouwYBueno-de-MesquitaB.White cell counts in relation to mortality in a general population of cohort study in the Netherlands: a mediating effect or not?BMJ Open. 2019;9(10):e030949.
20.
KimJHLeeYJParkB.Higher monocyte count with normal white blood cell count is positively associated with 10-year cardiovascular disease risk determined by Framingham risk score among community-dwelling Korean individuals. Medicine (Baltimore). 2019;98(17):e15340.
21.
HonoldLNahrendorfM.Resident and monocyte-derived macrophages in cardiovascular disease. Circ Res. 2018;122(1):113-127.
22.
AzabBZaherMWeiserbsKF, et al. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol. 2010;106(4):470-476.
23.
LiJHeDYuJ, et al. Dynamic status of SII and SIRI alters the risk of cardiovascular diseases: evidence from Kailuan cohort study. J Inflamm Res. 2022;15:5945-5957.
24.
GengYZhuDWuC, et al. A novel systemic inflammation response index (SIRI) for predicting postoperative survival of patients with esophageal squamous cell carcinoma. Int Immunopharmacol. 2018;65:503-510.
25.
WelshCWelshPMarkPB, et al. Association of total and differential leukocyte counts with cardiovascular disease and mortality in the UK Biobank. Arterioscler Thromb Vasc Biol. 2018;38(6):1415-1423.
26.
LeeCDFolsomARNietoFJChamblessLEShaharEWolfeDA.White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: atherosclerosis risk in communities study. Am J Epidemiol. 2001;154(8):758-764.
27.
HanKShiDYangL, et al. Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Ann Med. 2022;54(1):1667-1677.
28.
SCOT-HEART Investigators; NewbyDEAdamsonPD, et al. Coronary CT angiography and 5-year risk of myocardial infarction. N Engl J Med. 2018;379(10):924-933.
29.
BonaldiCPasquereauAHillC, et al. Hospitalizations for cardiovascular diseases attributable to tobacco smoking in France in 2015. Eur J Prev Cardiol. 2021;28(12):1327-1333.
30.
LubinJHCouperDLutseyPLWoodwardMYatsuyaHHuxleyRR.Risk of cardiovascular disease from cumulative cigarette use and the impact of smoking intensity. Epidemiology. 2016;27(3):395-404.
31.
DuncanMSFreibergMSGreevyRAJrKunduSVasanRSTindleHA.Association of smoking cessation with subsequent risk of cardiovascular disease. JAMA. 2019;322(7):642-650.
32.
HendriksHFJ. Alcohol and human health: what is the evidence?Annu Rev Food Sci Technol. 2020;11:1-21.
33.
LibbyPTherouxP.Pathophysiology of coronary artery disease. Circulation. 2005;111(25):3481-3488.
34.
EnsrudKGrimmRHJr.The white blood cell count and risk for coronary heart disease. Am Heart J. 1992;124(1):207-213.
35.
GurmHSBhattDLLincoffAM, et al. Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials. Heart. 2003;89:1200-1204.
36.
CoşansuNCKaraRÖYaldizMDikicierBS.New markers to predict the response to omalizumab in chronic spontaneous urticaria. Dermatol Ther. 2022;35:e15589.
37.
CosansuNCYuksekalGTuranUUmitferFYaldizMSevimli DikicierB.Investigation of systemic immune-inflammation index and systemic inflammation response index as an indicator of the anti-inflammatuary effect of isotretinoin in patients with acne vulgaris. Cutan Ocul Toxicol. 2022;41:174-178.
38.
LiJYuanYLiaoXYuZLiHZhengJ.Prognostic significance of admission systemic inflammation response index in patients with spontaneous intracerebral hemorrhage: a propensity score matching analysis. Front Neurol. 2021;12:718032.
39.
DongXNaoJGaoY.Peripheral monocyte count predicts outcomes in patients with acute ischemic stroke treated with rtPA thrombolysis. Neurotox Res. 2020;37:469-477.
40.
WeiXZhangZWeiJLuoC.Association of systemic immune inflammation index and system inflammation response index with clinical risk of acute myocardial infarction. Front Cardiovasc Med. 2023;10:1248655.
41.
JiangYTuXLiaoX, et al. New inflammatory marker associated with disease activity in gouty arthritis: the systemic inflammatory response index. J Inflamm Res. 2023;16:5565-5573.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
